▶ Click here for a larger view
European countries have announced that they will temporarily suspend the use of a novel coronavirus infection (Corona 19) vaccine by multinational pharmaceutical company AstraZeneca as a preventive measure.
According to AFP and Reuters news agency on the 11th (local time), health authorities in Denmark, Norway, Italy and Iceland announced that they had temporarily suspended the vaccine against Corona 19.
This was done as a prophylactic measure after reports of blood clots were formed in some who received the vaccine.
Earlier on the 7th, Austrian authorities revealed that a 49-year-old woman died of “severe coagulation disorder” after vaccination against AstraZeneca Corona 19. Currently, there is no evidence that there is a causal relationship with vaccination, but for the purpose of prevention, the manufacturing unit ( batch) will not be distributed or inoculated.
Austria stopped using the vaccine with the manufacturing unit’ABV5300′, which was supplied to 17 European countries, of which 4 countries, including Estonia, Latvia, Lithuania, and Luxembourg, have already stopped vaccination of the manufacturing unit vaccine.
Danish authorities said today that a 60-year-old woman who received the same manufacturing unit AstraZeneca vaccine used in Austria, died after forming a blood clot, said it would stop using the AstraZeneca vaccine for two weeks, Reuters said.
However, Danish authorities emphasized that this is a preventive measure, saying that at this time it is not possible to conclude whether there is a link between the vaccine and blood clots, and that investigation is necessary.
Norwegian health officials expressed concern and said they would stop using the vaccine while waiting for further information, and Iceland took the same step.
The Italian Medicines Agency (AIFA) also announced on the 11th that it has decided to temporarily stop using the AstraZeneca vaccine, which has a serial number of’ABV2856′.
The decision was due to two deaths in Sicily following the vaccination, the ANSA news agency said, citing sources.
However, AIFA emphasized that the decision to discontinue use of the vaccine was made as a preventive measure, and that a causal relationship with the’suspected case of serious side effects’ has not been confirmed.
However, in a statement that day, the European Medicines Agency (EMA) said in a statement that it was aware that some member states, including Denmark, had temporarily suspended AstraZeneca vaccination. It was revealed again and again.
EMA added that the benefit of the vaccine continues to outweigh its risks, and the EMA safety committee’s position is that the vaccine can continue to be vaccinated while investigations into clot-related cases are ongoing.
The British government advocated the AstraZeneca vaccine.
A spokesman for the Prime Minister’s Office told reporters, “It is clear that the AstraZeneca vaccine is safe and effective, and should be given with confidence when an opportunity comes.”
He added that Denmark emphasized that there is no clear link between vaccines and blood clots.
When asked if the British government had contact with Denmark, he said it was “common” to exchange information with foreign officials.
Swedish authorities also said that there was no reason to change the recommendations for use, as nothing suggests that the AstraZeneca vaccine caused this type of blood clots.
Spain also announced on the same day that it will continue to receive vaccination, as no cases of blood clots have been reported.
(London Choi Yoon-jung, Brussels Kim Jong-un, Rome Jeon Sung-hun)
[연합뉴스]
Copyrights ⓒ Yonhap News. Unauthorized reproduction and redistribution prohibited